| Fibrocell Science, Inc. (OTCBB:FCSC.OB), an autologous cellular therapeutic company focused on the development of innovative products for aesthetic, medical and scientific applications, today announced the first scientific presentation of data demonstrating the efficacy of LAVIV™ (azficel-T) in treating moderate-to-severe depressed acne scars. The data were presented at the American Society for Dermatologic Surgery (ASDS) annual meeting in Washington, D.C. LAVIV, which is made from a person&#x...continued FCSC |
Thursday, November 3, 2011
LAVIV(tm) (azficel-T) Demonstrates Improvement in Acne Scarring
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment